
Kitsada Wudhikarn MD
Hematologic Oncology
Advanced Hematology Fellow in Lymphoma
Join to view full profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Wudhikarn is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Chiang Mai University Faculty of MedicineClass of 2003
University of Iowa Health Care Medical CenterResidency, Internal Medicine
Certifications & Licensure
CA State Medical License 2012 - Present
MN State Medical License 2019 - 2022
IA State Medical License 2010 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Feasibility and outcomes of decentralized point-of-care CD19 CAR T cell for relapsed large B cell lymphoma in resource-limited settings.Koramit Suppipat, Supannikar Tawinwung, Ornnicha Sathitakorn, Chantiya Chanswangphuwana, Kanhatai Chiengthong
Molecular Therapy. Oncology. 2026-09-17 - Laboratory Concordance and Prognostic Impact of 10-Color Flow Cytometry and Next-Generation Sequencing-Based Immunoglobulin Gene Assay for Measurable Residual Disease ...Chantiya Chanswangphuwana, Wasithep Limvorapitak, Sirorat Kobbuaklee, Patsita Kansuwan, Kitsada Wudhikarn
International Journal of Laboratory Hematology. 2026-08-09 - Infections Within 100 Days of Idecabtagene Vicleucel and Impact on Survival for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis.Kitsada Wudhikarn, Lohith Gowda, Qiran Ye, Temitope Oloyede, Michael Martens
Transplantation and Cellular Therapy. 2026-06-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









